Location History:
- Osaka, JP (2017 - 2019)
- Suita, JP (2022)
Company Filing History:
Years Active: 2017-2024
Title: Reiko Waki: Innovator in Antisense Oligonucleic Acids
Introduction
Reiko Waki is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of molecular biology, particularly in the development of antisense oligonucleic acids. With a total of four patents to her name, Waki's work focuses on reducing hepatotoxicity in therapeutic applications.
Latest Patents
Waki's latest patents include innovative antisense oligonucleic acids designed to minimize hepatotoxicity. These inventions are characterized by a base length of not less than 7 nucleotides and not more than 30 nucleotides. The design includes 2',4'-bridged nucleic acids at both terminals, with non-bridged nucleic acid residues present in between. Additionally, one or more bases in the non-bridged nucleic acid residues are modified to enhance their efficacy.
Career Highlights
Reiko Waki is affiliated with Osaka University, where she conducts her research and development. Her work has garnered attention for its potential applications in therapeutic settings, particularly in the treatment of various diseases.
Collaborations
Waki collaborates with notable colleagues such as Satoshi Obika and Takao Inoue. Their combined expertise contributes to the advancement of research in the field of antisense oligonucleic acids.
Conclusion
Reiko Waki's innovative work in antisense oligonucleic acids represents a significant advancement in molecular biology. Her contributions are paving the way for safer therapeutic options in medicine.